(2023). Real-world evidence of nivolumab for non-small-cell lung cancer in a developing country.
Chicago Style (17th ed.) CitationReal-world Evidence of Nivolumab for Non-small-cell Lung Cancer in a Developing Country. 2023.
MLA (8th ed.) CitationReal-world Evidence of Nivolumab for Non-small-cell Lung Cancer in a Developing Country. 2023.
Warning: These citations may not always be 100% accurate.